Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.

Simple item page
dc.contributor.authorRishi, Pukhrajen_US
dc.contributor.authorRishi, Ektaen_US
dc.contributor.authorShroff, Daraiusen_US
dc.date.accessioned2009-05-23en_US
dc.date.accessioned2009-05-29T08:27:11Z
dc.date.available2009-05-23en_US
dc.date.available2009-05-29T08:27:11Z
dc.date.issued2009-05-23en_US
dc.description.affiliationShri Bhagwan Mahavir Vitreoretinal Services, Medical and Vision Research Foundations, Sankara Nethralaya, 18, College Road, Chennai - 600 006, Tamil Nadu, India. docrishi@yahoo.co.in.en_US
dc.identifier.citationRishi P, Rishi E, Shroff D. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia. Indian Journal of Ophthalmology. 2009 May-Jun; 57(3): 241-2en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/70491
dc.language.isoengen_US
dc.source.urihttps://www.ijo.inen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683442/en_US
dc.subject.meshAngiogenesis Inhibitors --therapeutic use
dc.subject.meshAntibodies, Monoclonal --therapeutic use
dc.subject.meshAntibodies, Monoclonal, Humanized
dc.subject.meshCombined Modality Therapy
dc.subject.meshFluorescein Angiography
dc.subject.meshHumans
dc.subject.meshInjections
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPhotochemotherapy
dc.subject.meshRetinal Diseases --diagnosis
dc.subject.meshRetinal Diseases --drug therapy
dc.subject.meshRetinal Diseases --physiopathology
dc.subject.meshRetinal Neovascularization --diagnosis
dc.subject.meshRetinal Neovascularization --drug therapy
dc.subject.meshRetinal Neovascularization --physiopathology
dc.subject.meshRetinal Vessels --pathology
dc.subject.meshTelangiectasis --diagnosis
dc.subject.meshTelangiectasis --drug therapy
dc.subject.meshTomography, Optical Coherence
dc.subject.meshTreatment Outcome
dc.subject.meshVascular Endothelial Growth Factor A --antagonists & inhibitors
dc.subject.meshVisual Acuity
dc.subject.meshVitreous Body
dc.subject.meshVascular Endothelial Growth Factor A --antagonists & inhibitors
dc.subject.meshVitreous Body
dc.titleCombined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.en_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Ophthalmology